Aberrant activation of NLRP3 inflammasome in colonic macrophages strongly associates with the occurrence and progression of ulcerative colitis.Although targeting NLRP3 inflammasome has been considered to be a potential therapy,the underlying mechanism through which pathway the intestinal inflammation is modulated remains controversial.By focusing on the flavonoid lonicerin,one of the most abundant constituents existed in a long historical anti-inflammatory and anti-infectious herb Lonicera japonica Thunb.,here we report its therapeutic effect on intestinal inflammation by binding directly to enhancer of zeste homolog 2(EZH2)histone methyltransferase.EZH2-mediated modification of H3K27me3 promotes the expression of autophagy-related protein 5,which in turn leads to enhanced auto-phagy and accelerates autolysosome-mediated NLRP3 degradation.Mutations of EZH2 residues(His 129 and Arg685)indicated by the dynamic simulation study have found to greatly diminish the protective ef-fect of lonicerin.More importantly,in vivo studies verify that lonicerin dose-dependently disrupts the NLRP3-ASC-pro-caspase-1 complex assembly and alleviates colitis,which is compromised by admin-istration of EZH2 overexpression plasmid.Thus,these findings together put forth the stage for further considering lonicerin as an anti-inflammatory epigenetic agent and suggesting EZH2/ATG5/NLRP3 axis may serve as a novel strategy to prevent ulcerative colitis as well as other inflammatory diseases.